| Name | Title | Contact Details |
|---|
HMP Holdings LLC is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. HMP Holdings LLC is based in Malvern, PA. You can find more information on HMP Holdings LLC at www.hmpcommunications.com
HealthSTAR Communications, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Clover Health is a data driven health insurance startup driving to improve the overall state of healthcare in America. We are hiring software engineers, data scientists, designers and product folks who can help us understand our members` wellness and steer them clear of any health risks down the road. Unlike other health insurance companies also embracing preventive health, Clover`s Medicare is built on technology from the ground-up. Integrating our systems with doctors, clinicians, and nurse practitioners, Clover`s data team helps healthcare professionals in the field intervene directly into patients` wellness to help them avoid acute health episodes. If you`re a passionate person and interested in changing healthcare for the better, then Clover may just be the place for you.
Aldera is the new name for Healthation. Healthation accelerated the business of healthcare. Aldera brings the focus and foresight to improve it. While our name has changed, our solutions remain resilient. Our service remains deeply rooted in customer commitment. The post-healthcare reform landscape is a frontier fraught with challenges. Our expert knowledge of the terrain and our flexible payer platform prepares healthcare payers and administrators to confidently navigate the shifts.
RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.